Canaan Partners Welcomes Dr. Andrew Firlik as Venture Associate; Dr. Firlik Brings Medical Expertise to Healthcare Investment Team.Business Editors/Health Writers ROWAYTON, Conn.--(BW HealthWire)--March 5, 2001 Canaan Partners, a national venture capital investment firm, today announced that Andrew Firlik, MD, has joined as Venture Associate in the firm's Rowayton, Conn. offices. Dr. Firlik joins Canaan's healthcare investment team to assess and manage investments in the healthcare field. Dr. Firlik is a physician specializing in neurological surgery. Prior to his involvement with Canaan, he served as a consultant to Mayfield Fund and several early stage healthcare companies. He is a co-founder and scientific advisory board member of Vertis Neuroscience, Inc., a medical device company in Seattle. He also co-founded LaunchCyte, LLC, a Pittsburgh-based healthcare seed-stage investor and business accelerator. Well respected in his field, Dr. Firlik has published more than 30 scientific articles in leading medical journals, written several textbook chapters and essays, and is the co-editor of a forthcoming book about cerebrovascular surgery. His scientific work has been presented at more than 40 international meetings. He studied biology at Cornell University and Oxford University, received his MBA from the University of Pittsburgh, and his MD from Cornell University Medical College. He currently holds a clinical faculty appointment at the Yale University School of Medicine. "Dr. Firlik's involvement with Canaan aids us immeasurably in our evaluation of potential healthcare investments and lends an expert point of view around the current state of the industry," said Harry Rein, founder and managing general partner of Canaan Partners. "His extensive experience in healthcare makes him an extremely valuable addition to the Canaan investment team." Dr. Firlik joins the healthcare investment team at Canaan that includes Harry Rein, Seth Rudnick, MD, and Brent Ahrens. Canaan has remained strongly committed to the healthcare market since the firm was founded in 1987, with current market capitalization among its healthcare investments totaling approximately $3 billion. About Canaan Partners Canaan Partners (http://www.canaan.com) is a national venture capital investment firm formed in 1987. Canaan Partners specializes in early stage venture capital for health care as well as Internet and information technology companies. Canaan Partners was an early backer in Capstone Turbine (CPST CPST Cable Programming Services Tier CPST Commission on Professionals in Science and Technology CPST Community Psychiatric Supportive Treatment (Ohio) CPST Child Passenger Safety Technician CPST Classical Perturbation Scattering Theory ), Centocor (CNTO CNTO China National Tourist Office ), Esperion (ESPR ESPR European Society of Paediatric Radiology ESPR Espressivo (music) ESPR Ethnicity and Social Policy Research Unit (University of Bradford) ESPR European Society of Paediatric Research ), Genaissance (GNSC GNSC Global NetOps Support Center (Defense Information Systems Agency Network Center) ), Matrix Pharmaceutical Inc. (MATX MATX Micro Advanced Technology Extended (motherboard type) MATX Micro ATX ), Orapharma (OPHM), Praecis Pharmaceuticals Inc. (PRCS PRCS Palestine Red Crescent Society PRCS Permit Required Confined Space PRCS Primary Reaction Control System PRCS Senior Chief Parachute Rigger (Naval Rating) PRCS Pseudorandom Chip Stream PRCS Project Revision Control System ), CommerceOne (CMRC CMRC Canadian Motosport Racing Club CMRC Commerce One Inc. (stock symbol) CMRC Caribbean Marine Research Center CMRC Crime Mapping Research Center CMRC Credit Management Research Centre (UK) ), E.piphany(EPNY)/Rightpoint, Concord Communications (CCRD CCRD Colorado Civil Rights Division CCRD Clear Certainty Rundown CCRD Center for Community Research and Development CCRD Climate Change Research Division (US DoE) CCRD Certified Chiropractic Rehabilitation Doctor ), Copper Mountain Networks (CMTN), ONI Systems (ONIS), IntraWare (ITRA), and Interact Commerce (IACT), along with dozens of other market-leading companies. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion